Holen Sie sich die Stockscreener-App
21.96
2.76%
0.59
Handel nachbörslich:
21.18
-0.78
-3.55%
Schlusskurs vom Vortag:
$21.37
Offen:
$21.74
24-Stunden-Volumen:
187.79K
Relative Volume:
1.79
Marktkapitalisierung:
$275.09M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-31.48M
KGV:
-21.12
EPS:
-1.04
Netto-Cashflow:
$-28.71M
1W Leistung:
+11.25%
1M Leistung:
+55.97%
6M Leistung:
+81.71%
1J Leistung:
-5.14%
1-Tages-Spanne:
$20.31
$23.02
1-Wochen-Bereich:
$18.85
$23.71
52-Wochen-Spanne:
$4.90
$25.97
Forte Biosciences Inc Stock (FBRX) Company Profile
Firmenname
Forte Biosciences Inc
Sektor
Branche
Telefon
(310) 618-6994
Adresse
3060 PEGASUS PARK DRIVE, DALLAS, CA
Vergleichen Sie FBRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FBRX
Forte Biosciences Inc
|
21.96 | 267.70M | 0 | -31.48M | -28.71M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-25 | Eingeleitet | Evercore ISI | Outperform |
| 2025-08-18 | Eingeleitet | Guggenheim | Buy |
| 2025-01-21 | Eingeleitet | TD Cowen | Buy |
| 2024-04-08 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2021-09-20 | Hochstufung | Chardan Capital Markets | Sell → Buy |
| 2021-09-03 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-09-03 | Herabstufung | Chardan Capital Markets | Buy → Sell |
| 2021-09-03 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2021-09-03 | Herabstufung | Truist | Buy → Hold |
| 2021-05-14 | Eingeleitet | B. Riley Securities | Buy |
| 2021-03-26 | Eingeleitet | Citigroup | Buy |
| 2020-08-28 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2020-08-25 | Eingeleitet | Truist | Buy |
Alle ansehen
Forte Biosciences Inc Aktie (FBRX) Neueste Nachrichten
Is Forte Biosciences Inc a good long term investment - earlytimes.in
Positive week for Forte Biosciences, Inc. (NASDAQ:FBRX) institutional investors who lost 1.7% over the past year - Yahoo Finance
Federated Hermes Inc. Buys New Shares in Forte Biosciences, Inc. $FBRX - MarketBeat
Stock Traders Purchase High Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - MarketBeat
Celiac Disease Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - The Manila Times
Forte Biosciences (FBRX) Stock Analysis Report | Financials & Insights - Benzinga
What downside risks could hit Forte Biosciences Inc. (37T) stockJuly 2025 Weekly Recap & Technical Pattern Based Buy Signals - Newser
Recent Research Analysts’ Ratings Changes for Forte Biosciences (FBRX) - Defense World
Forte Biosciences initiated with an Outperform at Evercore ISI - MSN
What analyst consensus implies for Forte Biosciences Inc. (37T) stockWatch List & Trade Opportunity Analysis Reports - Newser
Is Forte Biosciences Inc. stock a top pick in earnings seasonJuly 2025 Update & Trade Opportunity Analysis - Newser
How forex fluctuations impact Forte Biosciences Inc. (37T) stockTrade Ideas & Weekly Hot Stock Watchlists - Newser
Is Forte Biosciences Inc. stock attractive for passive investors2025 Market WrapUp & High Accuracy Trade Signal Alerts - Newser
Forte Biosciences Inc. (FBRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
18,856 Shares in Forte Biosciences, Inc. $FBRX Purchased by Envestnet Asset Management Inc. - MarketBeat
Forte Biosciences, Inc. (FBRX) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Forte Biosciences (NASDAQ:FBRX) Coverage Initiated by Analysts at Evercore ISI - MarketBeat
Forte Biosciences (NASDAQ:FBRX) Earns Outperform Rating from Analysts at Evercore ISI - Defense World
Forte Biosciences Target of Unusually High Options Trading (NASDAQ:FBRX) - MarketBeat
Analysts Set Forte Biosciences, Inc. (NASDAQ:FBRX) PT at $67.00 - Defense World
Why Forte Biosciences Inc. stock could benefit from AI revolution2025 Year in Review & AI Enhanced Market Trend Forecasts - BỘ NỘI VỤ
How does Forte Biosciences Inc (FBRX) change from a tortoise to a hare? - Setenews
Forte Biosciences, Inc. (NASDAQ:FBRX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Evercore ISI initiates coverage on Forte Biosciences stock with Outperform rating - Investing.com Australia
Vitiligo Pipeline Advancements Report 2025: DelveInsight Highlights Emerging Therapeutics Reshaping the Treatment Landscape - The Globe and Mail
FBRX: Evercore ISI Group Initiates Coverage with Outperform Rati - GuruFocus
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules - marketscreener.com
Forte Biosciences (NASDAQ: FBRX) approves Nasdaq Rule 5635(c)(4) inducement option grant - Stock Titan
What analysts say about Forte Biosciences Inc stockVolume Spike Alerts & Affordable Market Trading - earlytimes.in
Why Forte Biosciences Inc. (37T) stock is a strong buy callQuarterly Earnings Report & Technical Pattern Recognition Alerts - newser.com
What is Chardan Capital’s Estimate for FBRX FY2025 Earnings? - Defense World
Why Forte Biosciences Inc. (37T) stock appears on watchlists2025 Support & Resistance & Safe Entry Zone Tips - newser.com
Will Forte Biosciences Inc. stock gain from lower inflationJuly 2025 Intraday Action & AI Driven Stock Movement Reports - newser.com
Can Forte Biosciences Inc. (37T) stock deliver strong annual returnsJuly 2025 Setups & Low Risk Profit Maximizing Plans - newser.com
Is Forte Biosciences Inc. (37T) stock vulnerable to rate hikes2025 Price Targets & Safe Entry Momentum Stock Tips - newser.com
Will Forte Biosciences Inc. (37T) stock profit from AI boomJuly 2025 Spike Watch & Free Reliable Trade Execution Plans - newser.com
Published on: 2025-11-19 14:11:29 - newser.com
What drives Forte Biosciences Inc stock priceMid Cap Growth Trends & Budget Friendly Growth Tips - earlytimes.in
Why Forte Biosciences Inc. stock is in analyst buy zoneMarket Risk Summary & Technical Buy Zone Confirmations - newser.com
Developing predictive dashboards with Forte Biosciences Inc. data2025 Volume Leaders & Weekly Return Optimization Alerts - newser.com
Finanzdaten der Forte Biosciences Inc-Aktie (FBRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.36%
1.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):